Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 788

1.

Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.

Couturaud F, Kearon C, Leroyer C, Mercier B, Abgrall JF, Le Gal G, Lacut K, Oger E, Bressollette L, Ferec C, Lamure M, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2006 Dec;96(6):744-9.

PMID:
17139368
2.

Venous thrombotic risk in family members of unselected individuals with factor V Leiden.

Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR.

Thromb Haemost. 2000 Jun;83(6):817-21.

PMID:
10896231
3.

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van Der Meer J, Prins MH, Büller HR.

Ann Intern Med. 2001 Sep 4;135(5):322-7.

PMID:
11529695
5.

High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.

Baba-Ahmed M, Le Gal G, Couturaud F, Lacut K, Oger E, Leroyer C.

Thromb Haemost. 2007 Feb;97(2):171-5.

PMID:
17264942
6.

[The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].

Schramm W, Heinemann LA, Spannagl M, Dick A, Assmann A.

Dtsch Med Wochenschr. 2000 Jan 7;125(1-2):2-6. German.

PMID:
10650817
7.

Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

Blood. 2002 Mar 15;99(6):1938-42.

8.

Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.

Samama MM, Rached RA, Horellou MH, Aquilanti S, Mathieux VG, Plu-Bureau G, Elalamy I, Conard J.

Br J Haematol. 2003 Oct;123(2):327-34.

PMID:
14531916
9.

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.

Bank I, Libourel EJ, Middeldorp S, Van Pampus EC, Koopman MM, Hamulyák K, Prins MH, Van Der Meer J, Büller HR.

Arch Intern Med. 2004 Sep 27;164(17):1932-7.

PMID:
15451770
10.

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR.

Ann Intern Med. 1998 Jan 1;128(1):15-20.

PMID:
9424976
12.

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA.

Arch Intern Med. 2002 Nov 11;162(20):2357-60.

PMID:
12418950
13.

Factor V Leiden: the venous thrombotic risk in thrombophilic families.

Lensen R, Rosendaal F, Vandenbroucke J, Bertina R.

Br J Haematol. 2000 Sep;110(4):939-45.

PMID:
11054086
14.

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.

Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH.

Circulation. 1995 Nov 15;92(10):2800-2.

15.

Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?

Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.

Thromb Haemost. 1997 Dec;78(6):1480-3.

PMID:
9423798
16.

The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study.

Heit JA, Sobell JL, Li H, Sommer SS.

J Thromb Haemost. 2005 Feb;3(2):305-11.

17.

Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.

Rintelen C, Mannhalter C, Ireland H, Lane DA, Knöbl P, Lechner K, Pabinger I.

Br J Haematol. 1996 May;93(2):487-90.

PMID:
8639453
18.

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study.

Mäkelburg AB, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Lijfering WM.

Haematologica. 2010 Jun;95(6):1030-3. doi: 10.3324/haematol.2009.017061. Epub 2009 Dec 8.

19.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D; Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

PMID:
18217158
20.

Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?

Spannagl M, Heinemann LA, Schramm W.

Eur J Contracept Reprod Health Care. 2000 Jun;5(2):105-12.

PMID:
10943572

Supplemental Content

Support Center